Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Zen Rating
Momentum
Price
Volume
Vol 1d %
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
RSI
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D
MACD
MACD Signal
MACD Histogram
Beta
TLX
TELIX PHARMACEUTICALS LTD
$7.80195,000-12.16%8.809.209.7910.2013.4226.944.334.480.000.00-0.47-0.29-0.180.95
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
$2.1148,700-35.92%2.162.333.023.162.7834.9818.9214.5056.1833.99-0.25-0.270.020.69
HUMA
HUMACYTE INC
$1.117,280,00046.21%1.201.251.401.581.8837.1612.958.3517.198.60-0.07-0.06-0.011.59
NVAX
NOVAVAX INC
$6.666,910,00077.86%6.646.717.417.857.3743.0638.4931.8152.6632.81-0.19-0.240.041.73
QCLS
Q/C TECHNOLOGIES INC
$4.88962,0006.53%5.234.794.125.2413.1852.4926.6927.539.2610.410.250.36-0.111.21
OABI
OMNIAB INC
$2.093,285,000391.03%2.051.941.721.731.8363.7168.5567.3042.7543.890.110.110.000.67
ABVX
ABIVAX SA
$114.942,337,000141.43%119.25119.35108.0993.8452.2350.1019.3018.029.465.421.903.67-1.771.67
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC
$6.531,719,000229.94%7.126.879.9913.8413.1636.0025.0638.3542.1652.26-0.72-0.920.201.98
CLRB
CELLECTAR BIOSCIENCES INC
$2.6870,600185.83%3.383.423.584.306.2731.6316.2516.980.000.43-0.17-0.07-0.101.11
ANNX
ANNEXON INC
$5.1710,460,000286.69%4.924.643.743.142.6770.2570.1365.7352.4748.400.380.39-0.011.09
ORIC
ORIC PHARMACEUTICALS INC
$8.045,567,000372.18%9.2410.3211.7511.219.4519.971.262.700.000.00-0.98-0.74-0.241.13
HURA
TUHURA BIOSCIENCES INC
$0.82742,00022.24%1.071.491.982.322.7222.763.933.421.310.87-0.35-0.29-0.060.87
TARA
PROTARA THERAPEUTICS INC
$5.27975,00025.32%5.566.245.684.594.0741.679.8011.262.690.90-0.140.04-0.171.13
OCUL
OCULAR THERAPEUTIX INC
$12.567,004,00064.45%14.4513.2412.2012.2310.3646.0836.6746.8518.2230.730.480.63-0.151.50
XFOR
X4 PHARMACEUTICALS INC
$3.605,170,000803.85%3.743.673.583.333.8748.2352.5355.9947.7752.290.020.04-0.021.28
CRNX
CRINETICS PHARMACEUTICALS INC
$48.011,749,000-12.51%48.1946.8144.2939.1435.3156.3646.2252.3112.5515.981.251.44-0.201.20
RVPH
REVIVA PHARMACEUTICALS HOLDINGS INC
$0.604,519,000-44.80%0.650.600.580.520.6450.1237.2140.624.3313.580.020.02-0.010.75
NRSN
NEUROSENSE THERAPEUTICS LTD
$0.81480,000107.79%0.871.011.071.141.3233.605.685.280.000.98-0.08-0.05-0.020.59
MRNA
MODERNA INC
$33.8023,486,00071.53%29.9427.4826.4426.2427.5178.1088.3888.30100.0099.781.691.060.621.25
ANVS
ANNOVIS BIO INC
$3.65873,00045.02%3.954.253.032.712.4048.307.276.841.882.400.160.33-0.171.50
NGNE
NEUROGENE INC
$20.55403,00079.91%20.2020.3325.6822.8319.8744.9615.7811.3859.9651.22-1.28-1.480.201.46
IMMP
IMMUTEP LTD
$2.63360,00053.85%2.512.172.011.871.8169.2151.6148.8682.5779.420.210.150.051.00
QURE
UNIQURE NV
$23.997,286,000134.13%21.5223.7737.9931.5422.6041.4356.5242.87100.0093.33-3.44-4.441.001.38
CAPR
CAPRICOR THERAPEUTICS INC
$27.811,933,000112.42%27.0519.5711.539.309.8572.8560.7860.2647.3052.285.255.050.191.09
RNXT
RENOVORX INC
$0.93204,000124.18%0.930.900.981.071.1150.1047.3739.7142.1029.37-0.01-0.020.010.91
CADL
CANDEL THERAPEUTICS INC
$5.571,136,00075.58%5.795.275.265.425.6454.3447.3149.9642.7446.500.200.170.031.11
GANX
GAIN THERAPEUTICS INC
$2.8812,563,00085.71%3.753.472.692.222.0445.0139.3354.7323.3028.350.190.35-0.161.10
VYNE
VYNE THERAPEUTICS INC
$0.597,344,000-27.75%0.450.410.380.360.8776.5260.0158.5793.6279.690.040.020.021.12
LEXX
LEXARIA BIOSCIENCE CORP
$0.581,309,000177.92%0.961.021.000.991.0828.694.864.390.170.12-0.08-0.02-0.060.87
BEAM
BEAM THERAPEUTICS INC
$26.573,213,000130.82%26.7825.9425.1322.7920.9954.8348.0550.0221.0624.960.700.75-0.052.10
AVXL
ANAVEX LIFE SCIENCES CORP
$3.675,279,000195.91%4.063.955.997.818.5132.9216.9028.3353.0762.96-0.50-0.620.121.72
TENX
TENAX THERAPEUTICS INC
$13.10459,00029.66%10.9710.078.347.376.6485.9880.7882.94100.0096.921.150.850.300.44
NNVC
NANOVIRICIDES INC
$1.24344,00050.88%1.291.241.431.451.4245.3038.1041.2752.6455.43-0.05-0.060.010.82
MRKR
MARKER THERAPEUTICS INC
$1.28234,000-40.76%1.371.291.111.081.2252.9234.4340.982.942.970.070.09-0.021.08
NERV
MINERVA NEUROSCIENCES INC
$4.0419,50019.63%3.963.853.863.012.3553.4765.3370.5263.8271.070.050.050.000.51
IPSC
CENTURY THERAPEUTICS INC
$0.905,749,000102.22%0.640.580.570.540.5584.4988.6086.93100.0095.770.050.020.031.30
AMLX
AMYLYX PHARMACEUTICALS INC
$12.026,196,000349.31%12.7013.6113.7712.248.7534.687.235.974.441.84-0.46-0.22-0.241.19
AURA
AURA BIOSCIENCES INC
$5.86313,00074.86%6.236.195.966.186.2044.207.5819.433.832.620.030.11-0.071.10
AIXC
AIXCRYPTO HOLDINGS INC
$2.74103,000108.08%2.572.542.902.863.1551.6673.4973.4683.4184.44-0.05-0.110.060.67
ZURA
ZURA BIO LTD
$4.27288,00015.66%4.033.883.813.042.1562.5884.5485.3298.6399.320.130.080.050.28
ENVB
ENVERIC BIOSCIENCES INC
$5.0862,400-32.90%5.955.956.568.9912.5344.467.728.525.146.77-0.31-0.22-0.091.61
SRZN
SURROZEN INC
$21.7668,600-52.36%22.3019.2215.6413.6711.5663.1564.2866.356.2010.482.182.160.010.60
GHRS
GH RESEARCH PLC
$12.96777,000198.85%13.3513.9913.8113.5112.7742.1719.6316.4014.679.96-0.34-0.13-0.210.99
RYTM
RHYTHM PHARMACEUTICALS INC
$112.141,416,00040.34%110.25107.87106.41102.1883.2257.3353.7354.4460.2161.482.301.690.611.20
NKTR
NEKTAR THERAPEUTICS
$46.841,021,000-8.10%51.8355.5157.3748.8631.5338.8311.2211.1310.015.48-2.95-1.53-1.421.74
OVID
OVID THERAPEUTICS INC
$1.471,936,000-32.52%1.551.571.501.320.8447.4620.6719.7913.594.530.010.03-0.030.93
RVMD
REVOLUTION MEDICINES INC
$78.786,314,000112.74%78.1277.2266.1453.4745.8666.6449.0249.6210.464.903.304.17-0.881.33
OKUR
ONKURE THERAPEUTICS INC
$3.01240,000934.48%3.182.983.032.802.8749.5647.1248.4041.1042.500.030.03-0.000.76
RNAC
CARTESIAN THERAPEUTICS INC
$7.22298,00056.02%7.877.517.999.2510.6044.0129.8845.3136.9751.84-0.03-0.070.041.53
CRSP
CRISPR THERAPEUTICS AG
$55.863,284,000145.99%56.4455.0558.9658.9251.1049.1647.0149.7346.4748.82-0.31-0.540.231.53
ACLX
ARCELLX INC
$63.961,890,00091.10%68.8971.1581.0778.1171.5830.863.415.3536.7843.33-4.66-4.15-0.510.99
PRAX
PRAXIS PRECISION MEDICINES INC
$272.921,150,000229.51%268.57230.17190.95119.2380.1569.5387.8088.8270.3175.3427.5725.771.801.11
ADTX
ADITXT INC
$1.17587,000-74.46%2.062.5313.4161.58202.0920.965.997.0458.9457.04-3.87-5.081.210.58
CMND
CLEARMIND MEDICINE INC
$2.7479,500-13.59%3.384.6819.6730.1735.0317.299.928.5373.1859.31-4.46-5.310.850.30
CTMX
CYTOMX THERAPEUTICS INC
$4.0012,579,00035.83%4.034.053.803.072.3451.4147.7961.1822.1437.040.070.10-0.021.33
VTGN
VISTAGEN THERAPEUTICS INC
$0.787,414,000-28.67%3.273.833.993.643.0223.041.8122.120.5616.37-0.63-0.20-0.431.81
CVKD
CADRENAL THERAPEUTICS INC
$7.1168,000-21.84%9.609.6111.5212.1613.5033.766.6819.0935.0644.77-0.87-0.64-0.240.75
ATON
ALPHATON CAPITAL CORP
$0.72381,000-67.60%1.211.603.525.256.0318.034.476.171.560.52-0.75-0.780.021.16
SRPT
SAREPTA THERAPEUTICS INC
$21.046,508,000173.22%21.5921.0620.7819.8732.0651.1140.5052.6610.3024.060.380.45-0.070.96
PHVS
PHARVARIS NV
$25.59703,000398.58%24.3525.4423.9023.3920.2253.5121.3118.2018.4112.250.040.23-0.180.52
IFRX
INFLARX NV
$1.11809,000-8.28%1.051.091.241.221.1748.5547.9436.1776.5355.15-0.06-0.070.010.87
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
$3.431,228,00014.34%3.603.613.403.012.6446.8121.3031.606.8916.180.040.08-0.041.08
CBIO
CRESCENT BIOPHARMA INC
$11.85202,00032.03%13.3713.5912.9512.9216.6438.126.3010.300.000.20-0.150.11-0.261.19
CHRS
COHERUS ONCOLOGY INC
$1.361,063,00064.55%1.351.301.441.361.1251.5969.5872.9569.7373.76-0.00-0.020.021.57
CLNN
CLENE INC
$6.6897,00016.87%6.437.548.507.145.3243.4119.0117.9438.4130.27-0.68-0.63-0.050.79
ORKA
ORUKA THERAPEUTICS INC
$31.844,762,000659.49%30.1429.9328.3722.2216.7861.1149.1341.4228.6213.370.610.81-0.200.73
VSTM
VERASTEM INC
$7.765,574,000208.81%9.089.679.078.837.4833.314.164.840.170.06-0.280.04-0.321.57
INO
INOVIO PHARMACEUTICALS INC
$2.282,231,0001.87%2.252.092.192.182.0054.6364.7376.6065.8083.700.070.020.051.52
APGE
APOGEE THERAPEUTICS INC
$78.542,757,000202.63%76.3573.7963.8851.0144.8171.5782.8879.2532.8321.904.194.55-0.361.30
AVTX
AVALO THERAPEUTICS INC
$18.60685,000-10.57%19.0018.3817.0913.839.6353.5965.3263.6753.9150.980.610.67-0.060.89
CRDF
CARDIFF ONCOLOGY INC
$2.57897,00017.72%2.442.292.242.232.7965.6382.7474.2191.0282.980.080.050.031.51
TRDA
ENTRADA THERAPEUTICS INC
$10.98229,00045.86%10.9710.528.487.017.5866.8177.4383.778.7925.650.760.82-0.071.06
IMRX
IMMUNEERING CORP
$5.656,182,000439.44%5.956.536.426.134.1635.147.965.8014.807.14-0.30-0.17-0.131.27
NMRA
NEUMORA THERAPEUTICS INC
$1.751,267,00059.57%1.962.112.291.991.4931.185.314.113.811.27-0.16-0.11-0.051.40
DMAC
DIAMEDICA THERAPEUTICS INC
$8.48630,000-64.18%8.838.647.446.805.4853.8421.5625.418.174.750.360.48-0.120.86
NCEL
NEWCELX LTD
$2.6036,200409.86%3.243.436.9614.2016.5330.938.1110.9641.6243.19-1.07-1.270.200.41
CLYM
CLIMB BIO INC
$4.281,365,000-2.99%3.242.502.182.111.7078.2683.7884.1679.9987.050.620.340.280.76
BCAB
BIOATLA INC
$0.75959,00016.38%0.790.810.790.670.5345.3715.9915.3624.4418.88-0.010.00-0.011.77
ALEC
ALECTOR INC
$1.403,005,000131.69%1.371.311.622.101.7249.6864.4464.6972.2972.07-0.04-0.080.041.66
IMNN
IMUNON INC
$3.7540,40025.47%3.963.924.245.179.6339.044.1913.470.0011.07-0.09-0.100.010.92
ELAB
PMGC HOLDINGS INC
$2.2693,000-61.89%3.504.305.315.637.9016.855.195.792.040.68-0.78-0.53-0.251.25
BTAI
BIOXCEL THERAPEUTICS INC
$1.73789,000156.17%1.971.992.052.832.3339.474.876.403.222.79-0.06-0.04-0.021.64
ABEO
ABEONA THERAPEUTICS INC
$5.111,542,00082.05%5.174.984.945.605.6653.3240.0039.3825.2624.090.070.060.000.86
DNLI
DENALI THERAPEUTICS INC
$16.852,145,000126.98%17.7118.3517.1015.8215.0343.553.804.040.960.38-0.060.29-0.351.60
RZLT
REZOLUTE INC
$1.7710,975,00051.25%4.346.988.447.975.9924.647.998.309.849.61-2.10-1.33-0.770.67
DNTH
DIANTHUS THERAPEUTICS INC
$42.443,570,000512.35%42.3542.9638.7333.9726.6955.9232.3627.0013.466.370.801.26-0.460.97
PRQR
PROQR THERAPEUTICS NV
$2.21798,00096.07%2.252.202.372.272.0249.0541.7451.0144.3753.22-0.02-0.020.011.04
OSRH
OSR HOLDINGS INC
$0.65951,000164.17%0.620.660.620.631.0352.0621.169.0730.2612.47-0.010.00-0.010.00
AVIR
ATEA PHARMACEUTICALS INC
$3.141,218,000458.72%3.173.113.163.213.1749.9758.1867.0158.3271.290.010.000.010.98
VANI
VIVANI MEDICAL INC
$1.39494,000153.33%1.411.381.471.401.2848.2820.1625.1129.0529.73-0.02-0.020.001.14
PHIO
PHIO PHARMACEUTICALS CORP
$1.07423,00030.15%1.111.171.571.891.9430.146.917.533.566.98-0.13-0.140.011.21
SGMT
SAGIMET BIOSCIENCES INC
$6.281,020,00039.92%6.196.437.327.416.3143.3430.8725.4666.9546.33-0.36-0.370.012.12
GUTS
FRACTYL HEALTH INC
$2.208,186,000-11.28%2.241.951.541.341.4668.1375.4574.379.2920.190.230.23-0.001.00
ELDN
ELEDON PHARMACEUTICALS INC
$1.641,565,000180.47%1.621.602.432.562.8740.8143.2745.2270.4568.24-0.19-0.250.060.77
VIR
VIR BIOTECHNOLOGY INC
$5.765,157,000145.57%6.416.325.975.515.5942.3330.6446.033.7523.240.090.18-0.091.29
VERA
VERA THERAPEUTICS INC
$51.222,508,000202.17%47.4841.4033.8229.0226.2078.6188.0386.8960.4867.465.154.620.541.13
BHVN
BIOHAVEN LTD
$10.855,076,00084.25%10.9810.2212.1113.5216.2050.7075.7877.4074.4977.27-0.02-0.280.261.62
PDSB
PDS BIOTECHNOLOGY CORP
$0.89415,00017.23%0.940.870.901.021.1649.6540.0542.2638.3443.520.010.010.001.93
IRON
DISC MEDICINE INC
$80.044,225,000915.63%90.3791.5487.4874.5662.3533.6021.8323.8713.129.280.111.54-1.440.91
AGIO
AGIOS PHARMACEUTICALS INC
$24.463,773,000221.11%26.4427.0135.3936.5834.3830.583.074.100.006.97-2.82-2.970.151.24

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Alnylam Pharmaceuticals (NASDAQ:ALNY)


Alnylam Pharmaceuticals (NASDAQ:ALNY) is the #1 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Alnylam Pharmaceuticals (NASDAQ:ALNY) is: Value: C, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: B, and AI: B.

Alnylam Pharmaceuticals (NASDAQ:ALNY) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

ALNY passed 16 out of 33 due diligence checks and has strong fundamentals. Alnylam Pharmaceuticals has seen its stock return 67.55% over the past year, overperforming other biotech stocks by 108 percentage points.

Alnylam Pharmaceuticals has an average 1 year price target of $491.28, an upside of 22.75% from Alnylam Pharmaceuticals's current stock price of $400.23.

Alnylam Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 25 analysts covering Alnylam Pharmaceuticals, 48% have issued a Strong Buy rating, 36% have issued a Buy, 16% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Innoviva (NASDAQ:INVA)


Innoviva (NASDAQ:INVA) is the #2 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Innoviva (NASDAQ:INVA) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Innoviva (NASDAQ:INVA) has a Due Diligence Score of 45, which is 22 points higher than the biotech industry average of 23.

INVA passed 14 out of 33 due diligence checks and has strong fundamentals. Innoviva has seen its stock return 11.49% over the past year, overperforming other biotech stocks by 52 percentage points.

Innoviva has an average 1 year price target of $32.25, an upside of 61.33% from Innoviva's current stock price of $19.99.

Innoviva stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Innoviva, 25% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 25% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)


Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 617 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: C, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 53, which is 30 points higher than the biotech industry average of 23.

ONC passed 18 out of 33 due diligence checks and has strong fundamentals. Beone Medicines has seen its stock return 80.89% over the past year, overperforming other biotech stocks by 121 percentage points.

Beone Medicines has an average 1 year price target of $390.88, an upside of 23.68% from Beone Medicines's current stock price of $316.05.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Beone Medicines, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 11.79%, which is 9 percentage points higher than the biotech industry average of 2.89%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.28%, which is -1 percentage points lower than the biotech industry average of 2.89%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 49.4% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)


Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.55%, which is -2 percentage points lower than the biotech industry average of 2.89%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 64% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.35% in the last day, and down -0.7% over the last week. Cypherpunk Technologies was the among the top gainers in the biotechnology industry, gaining 39.04% yesterday.

Cypherpunk Technologies shares are trading higher after the company announced the appointment of Electric Coin Company CEO Josh Swihart as its Strategic Advisor.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 11.57% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 102.52% in the past year. It has overperformed other stocks in the biotech industry by 143 percentage points.

3. Innoviva (NASDAQ:INVA)


Innoviva (NASDAQ:INVA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has gained 11.49% in the past year. It has overperformed other stocks in the biotech industry by 52 percentage points.

Are biotech stocks a good buy now?

60.86% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 50.11% over the next year.

3.51% of biotech stocks have a Zen Rating of A (Strong Buy), 6.39% of biotech stocks are rated B (Buy), 46.19% are rated C (Hold), 31.13% are rated D (Sell), and 12.78% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 156.53x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.